Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Oxypaeoniflorin is a monoterpene glycoside that has been found in P. lactiflora and has diverse biological activities.1,2,3 It scavenges DPPH (Item No. 14805) radicals in a cell-free assay when used at concentrations of 800 and 1,000 µg/ml and inhibits LPS-induced nitric oxide (NO) production in RAW 264.7 macrophages at 250 µg/ml.1 Oxypaeoniflorin (10-40 mg/kg) decreases serum creatine kinase-MB (CK-MB), cardiac troponin I (CTnI), and cardiac troponin T (CTnT) levels and increases ejection fraction and fractional shortening in a mouse model of myocardial ischemia-reperfusion injury induced by left anterior descending coronary artery ligation.2 It increases survival and decreases lung inflammation severity scores and immune cell bronchoalveolar lavage fluid (BALF) infiltration in a mouse model of LPS-induced acute lung injury when administered at a dose of 40 mg/kg.3
WARNING This product is not for human or veterinary use.
1. Anti-
2. Oxypaeoniflorin improves myocardial ischemia/reperfusion injury by activating the Sirt1/Foxo1 signaling pathway. Acta Biochim. Pol. 67(2), 239-245 (2020).
3. Oxypaeoniflorin prevents acute lung injury induced by lipopolysaccharide through the PTEN/AKT pathway in a Sirt1-